Your browser doesn't support javascript.
loading
A pragmatic randomized clinical trial of insulin glargine 300 U/mL vs first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 6-month outcomes of the ACHIEVE Control study.
Meneghini, Luigi F; Sullivan, Sean D; Oster, Gerry; Busch, Robert; Cali, Anna M G; Dauchy, Arnaud; Gill, Jasvinder; Bailey, Timothy S.
Affiliation
  • Meneghini LF; University of Texas Southwestern Medical Center and Parkland Health and Hospital System, Dallas, Texas, USA.
  • Sullivan SD; CHOICE Institute, School of Pharmacy, University of Washington, Seattle, Washington, USA.
  • Oster G; Policy Analysis Inc., Brookline, Massachusetts, USA.
  • Busch R; Albany Medical College Faculty Practice: Community Endocrine Group, Albany, New York, USA.
  • Cali AMG; Sanofi, Paris, France.
  • Dauchy A; Sanofi, Paris, France.
  • Gill J; Sanofi, Bridgewater, New Jersey, USA.
  • Bailey TS; AMCR Institute, Escondido, California, USA.
Diabetes Obes Metab ; 22(11): 2004-2012, 2020 11.
Article in En | MEDLINE | ID: mdl-32729217
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Hypoglycemia Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Hypoglycemia Type of study: Clinical_trials / Prognostic_studies Limits: Adult / Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2020 Document type: Article Affiliation country: United States Country of publication: United kingdom